Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysis

BACKGROUND: We aimed to investigate the impact of a fourth dose of BNT162b2 vaccine (Comirnaty®, Pfizer-BioNTech) on anti-SARS-CoV-2 (anti-S IgG) antibody titers in patients receiving hemodialysis (HD) and healthcare workers (HCWs). METHODS: A multi-institutional retrospective study at five dialysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanai, Daisuke, Wakui, Hiromichi, Hanaoka, Masaaki, Haze, Tatsuya, Azushima, Kengo, Shinoda, Satoru, Tsukamoto, Shunichiro, Taguchi, Shinya, Kinguchi, Sho, Kanaoka, Tomohiko, Toya, Yoshiyuki, Hirawa, Nobuhito, Kato, Hideaki, Watanabe, Fumimasa, Hanaoka, Kanako, Mitsuhashi, Hiroshi, Yamaguchi, Satoshi, Ohnishi, Toshimasa, Tamura, Kouichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047466/
https://www.ncbi.nlm.nih.gov/pubmed/36977892
http://dx.doi.org/10.1007/s10157-023-02342-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047466/
https://www.ncbi.nlm.nih.gov/pubmed/36977892
http://dx.doi.org/10.1007/s10157-023-02342-0

Ejemplares similares